AstraZeneca, Hutchmed's Lung Cancer MET Inhibitor Approved in China

Retrieved on: 2021-06-22 18:33:45

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca, Hutchmed's Lung Cancer MET Inhibitor Approved in China. View article details on hiswai:

Excerpt

NEW YORK – China's National Medical Products Administration (NMPA) has granted conditional approval to Hutchmed and AstraZeneca's MET ...

Article found on: www.precisiononcologynews.com